EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Formulation Optimization of Sinomenine-Loaded Nanostructured Lipid Carriers Based on Molecular Dynamics Simulations and Evaluation of Pharmacological Efficacy in Rheumatoid Arthritis

Xinmeng Lin, Xuehui Ding, Yunlu Zou, Mingyang Sheng, Jingying Li, Yinghao Xiao, Jiahui Xu, Jixin Li, Lin Wang, Wei Xu iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xinmeng Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China. Hauptthemen laut MEDLINE: Morphinans, Arthritis, Rheumatoid, Drug Carriers, Lipids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changchun University of Chinese Medicine Golden Seed Program, the National Undergraduate Training Program for Innovation and Entrepreneurship, the Science and Technology Development Program Project of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sinomenine (SIN), as a potential therapeutic agent for rheumatoid arthritis (RA), exhibits advantages such as non-addictiveness. However, its low aqueous solubility and poor membrane permeability result in limited bioavailability, which compromises its therapeutic efficacy in conventional formulations. To address these limitations, this study developed nanostructured lipid carriers (NLCs) with optimized formulations and evaluated their pharmacodynamic performance. Molecular dynamics (MD) simulations were employed to screen excipients and analyze the blending system. SIN-loaded NLCs (SIN-NLCs) were prepared using high-pressure homogenization. Single-factor experiments were performed to optimize the processing conditions of SIN-NLCs. A three-factor, three-level experimental design was established using Design Expert 13 software and further refined through Box–Behnken design (BBD) response surface methodology. This approach enabled cross-validation between molecular dynamics simulations and conventional experiments. Additionally, transmission electron microscopy (TEM) was used to examine morphology, while X-ray diffraction analysis (XRD), differential scanning calorimetry (DSC), and Fourier-transform infrared spectroscopy (FT-IR) were employed to characterize the physicochemical state of SIN in NLCs. Pharmacodynamic evaluation was performed in a RA model, supplemented by single-pass intestinal perfusion study (SPIP). Initially, MD simulations were employed to evaluate drug–excipient compatibility, thereby identifying suitable formulation excipients: stearic acid and oleic acid as lipid components, and Poloxamer 188 as the surfactant. Subsequently, single-factor experiments combined with the BBD response surface methodology were employed to optimize preparation parameters, establishing the ideal process conditions: drug-to-lipid ratio of 1:42, solid-to-liquid lipid ratio of 5.58:4.42, and Poloxamer 188 concentration of 1.20%. The optimized SIN-NLCs exhibited spherical particles with uniform dispersion and no agglomeration. The average particle size was 173.90 ± 1.97 nm, with a polydispersity index (PDI) of 0.18 ± 0.01, a zeta potential of −22.65 ± 0.60 mV, and an encapsulation efficiency (EE%) of 91.27% ± 0.01. Spectroscopic analysis confirmed that SIN existed in an amorphous state and was successfully encapsulated within the lipid matrix. In vivo, SIN-NLCs significantly reduced paw swelling and arthritis scores in model rats, promoted synovial cell proliferation, and suppressed inflammatory cell infiltration. The intestinal perfusion study demonstrated that SIN-NLCs were primarily absorbed in the small intestine and markedly enhanced drug permeability. SIN-NLCs represent an effective delivery system to enhance the solubility and permeability of SIN. This study provides a novel strategy and methodology for the formulation of hydrophobic drugs, offering valuable insights for future pharmaceutical development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MorphinansArthritis, RheumatoidDrug CarriersLipidsNanostructuresMolecular Dynamics SimulationAnimalsRatsMaleX-Ray DiffractionSpectroscopy, Fourier Transform InfraredDrug Compounding

Stichwörter der Autor:innen

Sinomeninemolecular dynamics simulationsnanostructured lipid carrierpharmacodynamicssingle-pass intestinal perfusion

Substanzen

sinomenineMorphinansDrug CarriersLipids

Autor:innen und Institutionen

  • School of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.

ORCID-Profile: Wei Xu

Förderung

  • Changchun University of Chinese Medicine Golden Seed Program
  • the National Undergraduate Training Program for Innovation and Entrepreneurship
  • the Science and Technology Development Program Project of Jilin Province

Zitieren

APA

Lin, X., Ding, X., Zou, Y., Sheng, M., Li, J., Xiao, Y., Xu, J., Li, J., Wang, L., & Xu, W. (2025). Formulation Optimization of Sinomenine-Loaded Nanostructured Lipid Carriers Based on Molecular Dynamics Simulations and Evaluation of Pharmacological Efficacy in Rheumatoid Arthritis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311449

Vancouver

Lin X, Ding X, Zou Y, Sheng M, Li J, Xiao Y, et al. Formulation Optimization of Sinomenine-Loaded Nanostructured Lipid Carriers Based on Molecular Dynamics Simulations and Evaluation of Pharmacological Efficacy in Rheumatoid Arthritis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311449

BibTeX
@article{Lin2025,
  author = {Lin, Xinmeng and Ding, Xuehui and Zou, Yunlu and Sheng, Mingyang and Li, Jingying and Xiao, Yinghao and Xu, Jiahui and Li, Jixin and Wang, Lin and Xu, Wei},
  title = {Formulation Optimization of Sinomenine-Loaded Nanostructured Lipid Carriers Based on Molecular Dynamics Simulations and Evaluation of Pharmacological Efficacy in Rheumatoid Arthritis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311449}
}
Kostenlos starten →